CH611910A5 - - Google Patents

Info

Publication number
CH611910A5
CH611910A5 CH1020975A CH1020975A CH611910A5 CH 611910 A5 CH611910 A5 CH 611910A5 CH 1020975 A CH1020975 A CH 1020975A CH 1020975 A CH1020975 A CH 1020975A CH 611910 A5 CH611910 A5 CH 611910A5
Authority
CH
Switzerland
Application number
CH1020975A
Inventor
Otto Dr Engelfried
Ulrich Dr Kerb
Rudolf Prof Dr Wiechert
Helmut Dr Wachtel
Dieter Dr Palenschat
Reinhard Dr Horowski
Gert Dr Paschelke
Wolfgang Dr Kehr
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of CH611910A5 publication Critical patent/CH611910A5/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J7/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/0005Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
    • C07J7/001Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group
    • C07J7/0015Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa
    • C07J7/002Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa not substituted in position 16

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
CH1020975A 1974-08-05 1975-08-05 CH611910A5 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2438020A DE2438020A1 (de) 1974-08-05 1974-08-05 18-methyl-19-nor-20-keto-pregnane und verfahren zu ihrer herstellung

Publications (1)

Publication Number Publication Date
CH611910A5 true CH611910A5 (da) 1979-06-29

Family

ID=5922668

Family Applications (1)

Application Number Title Priority Date Filing Date
CH1020975A CH611910A5 (da) 1974-08-05 1975-08-05

Country Status (17)

Country Link
US (1) US4029777A (da)
JP (1) JPS5141347A (da)
AT (1) AT345998B (da)
BE (1) BE832124A (da)
CA (1) CA1037027A (da)
CH (1) CH611910A5 (da)
CS (2) CS175498B2 (da)
DD (1) DD120192A5 (da)
DE (1) DE2438020A1 (da)
DK (1) DK136369C (da)
ES (1) ES439720A1 (da)
FR (1) FR2281123A1 (da)
GB (1) GB1512258A (da)
HU (1) HU171684B (da)
IL (1) IL47770A (da)
NL (1) NL7509326A (da)
SE (1) SE404804B (da)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61144199A (ja) * 1984-12-18 1986-07-01 Pioneer Electronic Corp スピ−カ用紙製振動部材の製造方法
AU609927B2 (en) * 1987-08-25 1991-05-09 Kelvin W. Gee Compositions and methods for alleviating stress, anxiety and seizure activity
US5232917A (en) * 1987-08-25 1993-08-03 University Of Southern California Methods, compositions, and compounds for allosteric modulation of the GABA receptor by members of the androstane and pregnane series
US5175154A (en) * 1987-11-25 1992-12-29 Research Corporation Technologies, Inc. 5 α-pregnan-20-ones and 5-pregnen-20-ones and related compounds
WO2014169831A1 (en) 2013-04-17 2014-10-23 Sage Therapeutics, Inc. 19-nor c3,3-disubstituted c21-c-bound heteroaryl steroids and methods of use thereof
WO2014169836A1 (en) 2013-04-17 2014-10-23 Sage Therapeutics, Inc. 19-nor neuroactive steroids and methods of use thereof
CN108440633B (zh) 2013-04-17 2021-07-13 萨奇治疗股份有限公司 19-去甲c3,3-二取代的c21-n-吡唑基类固醇及其使用方法
ES2807264T3 (es) 2013-04-17 2021-02-22 Sage Therapeutics Inc Esteroides neuroactivos 19-nor para métodos de tratamiento
HUE053900T2 (hu) 2013-07-19 2021-07-28 Sage Therapeutics Inc Neuroaktív szteroidok, kompozíciók, és azok alkalmazásai
BR112016003862B1 (pt) 2013-08-23 2022-09-06 Sage Therapeutics, Inc Compostos esteroides neuroativos, suas composições e seus usos
WO2015195962A1 (en) 2014-06-18 2015-12-23 Sage Therapeutics, Inc. Neuroactive steroids, compositions, and uses thereof
SG10202009859YA (en) 2014-10-16 2020-11-27 Sage Therapeutics Inc Compositions and methods for treating cns disorders
EP3206493B1 (en) 2014-10-16 2020-05-06 Sage Therapeutics, Inc. Compositions and methods for treating cns disorders
ME03749B (me) 2014-11-27 2021-04-20 Sage Therapeutics Inc KOMPOZICIJE I POSTUPCIZA LEČENJE POREMEĆAJA CNS-a
RS61530B1 (sr) 2015-01-26 2021-04-29 Sage Therapeutics Inc Kompozicije i postupci za lečenje poremećaja cns
WO2016134301A2 (en) 2015-02-20 2016-08-25 Sage Therapeutics, Inc. Neuroactive steroids, compositions, and uses thereof
US20190233465A1 (en) 2016-07-11 2019-08-01 Sage Therapeutics, Inc. C7, c12, and c16 substituted neuroactive steroids and their methods of use
DK3481845T3 (da) 2016-07-11 2023-11-27 Sage Therapeutics Inc C17, c20 og c21 substituerede neuroaktive steroider og deres anvendelsesmetoder
EP3728284A1 (en) * 2017-12-22 2020-10-28 Sage Therapeutics, Inc. Compositions and methods for treating cns disorders
JOP20210293A1 (ar) 2019-05-31 2023-01-30 Sage Therapeutics Inc ستيرويدات ذات فعالية عصبية وتركيبات منها

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE791196A (fr) * 1971-11-11 1973-05-10 Glaxo Lab Ltd Nouveaux steroides, leur procede de preparation et leurs applications
GB1409239A (en) * 1971-11-11 1975-10-08 Glaxo Lab Ltd Process for the preparation of 3alpha-hydroxy-5alpha-steroids

Also Published As

Publication number Publication date
CS175498B2 (da) 1977-05-31
DE2438020A1 (de) 1976-02-26
DK136369C (da) 1978-02-27
NL7509326A (nl) 1976-02-09
SE7508777L (sv) 1976-02-06
DK344475A (da) 1976-02-06
ES439720A1 (es) 1977-03-01
HU171684B (hu) 1978-02-28
IL47770A (en) 1978-10-31
DK136369B (da) 1977-10-03
JPS5141347A (en) 1976-04-07
AT345998B (de) 1978-10-10
DD120192A5 (da) 1976-06-05
CA1037027A (en) 1978-08-22
FR2281123A1 (fr) 1976-03-05
US4029777A (en) 1977-06-14
AU8351575A (en) 1977-02-03
CS175500B2 (da) 1977-05-31
BE832124A (fr) 1976-02-05
SE404804B (sv) 1978-10-30
GB1512258A (en) 1978-05-24
IL47770A0 (en) 1975-10-15
ATA600475A (de) 1978-02-15

Similar Documents

Publication Publication Date Title
JPS50142809A (da)
CS175498B2 (da)
FR2288022B1 (da)
FR2266312B3 (da)
FR2274373B1 (da)
AU7459574A (da)
AU7237274A (da)
JPS50124794U (da)
AR198841Q (da)
JPS50129906A (da)
JPS50106203U (da)
JPS50109824A (da)
CH580858A5 (da)
CH578561A5 (da)
CH577283A5 (da)
CH575490A5 (da)
CH577330A5 (da)
CH577049A5 (da)
CH575720A5 (da)
AU480501A (da)
BG20232A1 (da)
CH576624A5 (da)
CH599096A5 (da)
AU480759A (da)
CH579578A5 (da)

Legal Events

Date Code Title Description
PL Patent ceased